Teresa M.
- Country
- Austria
- Department
- Uniklinikum Salzburg Landeskrankenhaus Universitätsklinik für Innere Medizin III
Research Overview
- Phase I Study of BI 764532 Dose Tolerability in Patients with DLL3-Positive Glioma
- Phase 3 Randomized Open‑Label Study of ZL‑1310 versus Investigator‑Chosen Topotecan in Relapsed Small Cell Lung Cancer
- Phase II Multicenter Trial of Patritumab Deruxtecan in HER3-Expressing Advanced Breast and Non-Small Cell Lung Cancer with Brain Metastases and Leptomeningeal Carcinomatosis
Data & Insights
Has run more than one trial at 145 of 354 partner sites.
Specializations
Lung Cancer Research
Specializes in advanced therapeutic approaches for non-small cell lung cancer (NSCLC), with particular focus on targeted treatments for specific genetic mutations.
- HER2 mutations in NSCLC
- EGFR mutation-positive lung cancer
- MET-overexpressed lung cancers
Investigates novel therapeutic combinations and targeted approaches for treatment-resistant forms of lung cancer.
Neuro-Oncology
Conducts research in the treatment of brain tumors, specifically focusing on DLL3-positive gliomas and innovative therapeutic approaches.
- Brain tumor therapeutics
- DLL3-targeted treatments
- Novel glioma interventions
Explores targeted therapeutic strategies for specific molecular markers in brain tumors.
Head and Neck Cancer
Focuses on treatment strategies for recurrent and metastatic head and neck squamous cell carcinoma, particularly investigating immunotherapy combinations.
- PD-L1 positive cancers
- Combination immunotherapy
- Advanced squamous cell carcinoma
Evaluates innovative therapeutic combinations to enhance treatment outcomes in head and neck cancers.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.